335 results on '"Petrini, Iacopo"'
Search Results
2. Single-cell sequencing has revealed a more complex array of thymic epithelial cells
3. Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
4. Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib
5. Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC
6. STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
7. Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer
8. Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival
9. Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation
10. Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
11. Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies
12. Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities
13. A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
14. Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA
15. erbB in NSCLC as a molecular target: current evidences and future directions
16. Editorial: Primary and acquired resistance in lung cancer
17. Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
18. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management.
19. Molecular and Functional Key Features and Oncogenic Drivers in Thymic Carcinomas.
20. Somatic mutations of thymic epithelial tumors with myasthenia gravis
21. The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
22. Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment
23. Mesenchymal Stem Cell in Pancreatic Islet Transplantation
24. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer
25. PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
26. Supplementary Figure Legend from Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors
27. Supplementary Figure 2 from Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors
28. Supplementary Figure 1 from Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors
29. Supplementary Figures 1-3, Tables 1-6 from Loss of 18q22.3 Involving the Carboxypeptidase of Glutamate-like Gene Is Associated with Poor Prognosis in Resected Pancreatic Cancer
30. Supplementary Figure 3 from Copy Number Aberrations of Genes Regulating Normal Thymus Development in Thymic Epithelial Tumors
31. Data from MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma
32. Supplementary Figure 1 from MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma
33. Supplementary Tables 1-9 from MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma
34. Supplementary Appendix 1 from MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non–Small Cell Lung Carcinoma
35. The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report
36. Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations
37. Nanoscale engagement of immune checkpoint inhibitor PD-L1 in membrane lipid rafts
38. A patient with a Germline (p.R776H) EGFR Mutation With Multiple Lung Cancers Harboring Different Somatic EGFR Mutations
39. Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations
40. ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach
41. Additional file 1 of Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
42. Additional file 6 of Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
43. Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
44. Thymectomy in Myasthenic Patients With Thymoma: Killing Two Birds With One Stone
45. Detecting cell-of-origin and cancer-specific methylation features of cell-free DNA from Nanopore sequencing
46. Expression and Mutational Status of c-kit in Thymic Epithelial Tumors
47. Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives
48. Additional file 3 of Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
49. Additional file 1 of Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients
50. Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.